Condition
Autoimmune Rheumatic Diseases
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 4 (4)
Trial Status
Recruiting3
Not Yet Recruiting2
Clinical Trials (5)
Showing 5 of 5 trials
NCT07275580Phase 4Not Yet RecruitingPrimary
Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases
NCT07341386Phase 4RecruitingPrimary
Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases
NCT07731672Not ApplicableNot Yet RecruitingPrimary
Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases
NCT07242092Phase 4RecruitingPrimary
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
NCT07280741Phase 4RecruitingPrimary
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators
Showing all 5 trials